Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy

Abstract

Objective:

To evaluate the characteristics and risk factors for locoregional recurrence in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated radiotherapy (IMRT).

Methods:

The clinical diagnosis and treatment data of 195 patients with NPC treated with IMRT from March 2005 to May 2010 (including 9, 24, 70, and 92 cases of stage I, II, III, and IV disease, respectively, according to the 7th edition American Joint Committee on Cancer staging criteria) were retrospectively analyzed. The Kaplan-Meier method was used for survival analysis, and logistic regression was used to conduct univariate and multivariate analyses.

Results:

The 5-year recurrence rate was 10.8%, and the 5-year local and regional recurrence rates were 8.7% and 3.4%, respectively. Multivariate analysis showed that the short axis of the cervical lymph nodes (≥3 cm) was an influencing factor for regional lymph node recurrence after IMRT.

Conclusion:

In-field and high-dose region failures were the main patterns associated with local-regional recurrence, and nasopharyngeal recurrence was most commonly detected. Newly diagnosed patients with large cervical lymph nodes (short diameter ≥3 cm) should be carefully followed up considering regional lymph node recurrence.

Keywords

intensity-modulated radiotherapy patterns of local-regional failure nasopharyngeal carcinoma

Get full access to this article

View all access options for this article.

References

Lai

Chen

et al . How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys. 2011;80(3):661-668.

Wei

Sham

JS.

Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041-2054.

Jiang

Jin

Feng

Jin

Chen

XZ.

Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: the Zhejiang Cancer Hospital’s experience. J Cancer Res Ther. 2015;11(suppl 2):C179-C184.

Lin

Pan

Han

et al . Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin. Radiother Oncol. 2014;110(3):385-389.

Lin

Pan

Han

Zhang

Liao

JJ.

Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009;75(4):1071-1078.

Yin

Bian

Wang

et al . Long-term results of concurrent chemoradiotherapy for advanced N2-3 stage nasopharyngeal carcinoma. PLoS One. 2015;10(9):e0137383.

Kong

Ying

et al . Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiat Oncol. 2014;9:60.

Huang

Jiang

et al . Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy. Radiat Oncol. 2014;9:87.

Dawson

Anzai

Marsh

et al . Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46(5):1117-1126.

10.

Lee

Hung

et al . Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79(2):420-428.

11.

Lee

Foo

Law

et al . Reirradiation for recurrent nasopharyngeal carcinoma: factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys. 1997;38(1):43-52.

12.

Zheng

Zhang

Zou

Chen

WQ.

Nasopharyngeal carcinoma incidence and mortality in China in 2009. Chin J Cancer. 2013;32(8):453-460.

13.

Huang

Han

Chen

Xiao

WW.

Clinical features of 337 patients with recurrent nasopharyngeal carcinoma. Chin J Cancer. 2010;29(1):82-86.

14.

Teo

Lee

et al . Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 1996;36(2):291-304.

15.

Nasr

Chahed

Bouaouina

Chouchane

Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression. Clin Clim Acta. 2008;395(1-2):124-129.

16.

Lui

Yau

Cheung

et al . FGF8b oncogene mediates proliferation and invasion of Epstein-Barr virus-associated nasopharyngeal carcinoma cells: implication for viral-mediated FGF8b upregulation. Oncogene. 2011;30(13):1518-1530.

17.

Strazzulla

Barreca

Giancotti

et al . Nasopharyngeal carcinoma: review of the literature with a focus on therapeutical implications. Infez Med. 2015;23(3):224-229.

18.

Zhu

et al . A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy. Tumour Biol. 2016;37(3):2941-2949.

19.

Wei

Cheng

et al . Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study. Arch Otolaryngol Head Neck Surg. 2001;127(12):1457-1462.

20.

Wang

et al . Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study. Radiother Oncol. 2014;112(1):106-111.

21.

Chen

Fee

Chen

et al . Salvage treatment for locally recurrent nasopharyngeal carcinoma (NPC). Am J Clin Oncol. 2014;37(4):327-331.

22.

Hua

Han

et al . Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. Eur J Cancer. 2012;48(18):3422-3428.